T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Globus Medical
GMED
$11.5B
| $60.8M | 0.01% |
695,959
-395,773
| -36% | -$30M |
|
752
Emcor
EME
$36.7B
| $60.7M | 0.01% |
99,268
-119,506
| -55% | -$77.4M |
|
753
Skyward Specialty Insurance
SKWD
$2.39B
| $60.5M | 0.01% |
1,183,920
+33,677
| +3% | +$1.62M |
|
754
Alexandria Real Estate Equities
ARE
$8.33B
| $60.3M | 0.01% |
1,232,975
+348,179
| +39% | +$20.5M |
|
755
Synaptics
SYNA
$4.2B
| $60.3M | 0.01% |
814,684
+671,647
| +470% | +$47.2M |
|
756
Fluence Energy
FLNC
$2.44B
| $60.2M | 0.01% |
3,045,780
+2,991,292
| +5,490% | +$56.4M |
|
757
Guidewire Software
GWRE
$15.2B
| $59.7M | 0.01% |
297,036
+23,256
| +8% | +$5.14M |
|
|
PCH
758
DELISTED
PotlatchDeltic
PCH
| $59.6M | 0.01% |
1,497,014
+1,422,670
| +1,914% | +$57.6M |
|
759
FirstService
FSV
$6.18B
| $59.4M | 0.01% |
382,075
-371,816
| -49% | -$60.5M |
|
|
MRX
760
Marex Group Limited Ordinary Shares
MRX
$5.2B
| $59.4M | 0.01% |
1,548,637
+337,444
| +28% | +$11.5M |
|
761
Raymond James Financial
RJF
$34.8B
| $59.1M | 0.01% |
367,988
-9,164
| -2% | -$1.48M |
|
762
Agilent Technologies
A
$42.2B
| $59M | 0.01% |
433,486
-11,927
| -3% | -$1.71M |
|
763
D.R. Horton
DHI
$41.9B
| $58.8M | 0.01% |
407,901
+962
| +0.2% | +$146K |
|
764
Payoneer
PAYO
$2.42B
| $58.7M | 0.01% |
10,436,470
+182,614
| +2% | +$1.06M |
|
765
Public Service Enterprise Group
PEG
$37.8B
| $58.6M | 0.01% |
729,595
+2,457
| +0.3% | +$200K |
|
766
Woodward
WWD
$21.2B
| $58.4M | 0.01% |
193,009
-13,195
| -6% | -$3.63M |
|
767
Vulcan Materials
VMC
$36B
| $58.3M | 0.01% |
204,437
-412,738
| -67% | -$121M |
|
768
Prudential Financial
PRU
$43B
| $58.1M | 0.01% |
515,114
-193
| -0% | -$20.7K |
|
769
Granite Construction
GVA
$5.41B
| $58.1M | 0.01% |
503,906
+361,741
| +254% | +$38.9M |
|
770
EnerSys
ENS
$7.2B
| $57.6M | 0.01% |
392,781
+304,018
| +343% | +$40.6M |
|
771
nCino
NCNO
$2.26B
| $57.4M | 0.01% |
2,236,694
+627,413
| +39% | +$15.9M |
|
772
ATI
ATI
$30.9B
| $57.2M | 0.01% |
498,177
-575,972
| -54% | -$56.1M |
|
773
Peloton Interactive
PTON
$2.44B
| $57.1M | 0.01% |
9,272,961
-833,250
| -8% | -$5.87M |
|
774
Merit Medical Systems
MMSI
$5.4B
| $56.8M | 0.01% |
644,863
+4,016
| +0.6% | +$342K |
|
775
Moelis & Co
MC
$5.21B
| $56.8M | 0.01% |
825,722
+74,270
| +10% | +$4.96M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.